Prolonged course of pure red cell aplasia after erythropoietin therapy
- 30 September 2004
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 73 (5) , 376-379
- https://doi.org/10.1111/j.1600-0609.2004.00317.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment of erythropoietin-induced pure red cell aplasia: a retrospective studyThe Lancet, 2004
- Pure red cell aplasia in patients with refractory anaemia treated with two different recombinant erythropoietinsBritish Journal of Haematology, 2004
- Recovery from Pure Red Cell Aplasia Caused by Anti Erythropoietin Antibodies After Kidney TransplantationAmerican Journal of Transplantation, 2004
- Pure Red-Cell Aplasia Secondary to Antierythropoietin AntibodiesNew England Journal of Medicine, 2003
- Pure red-cell aplasia due to anti-erythropoietin antibodiesNephrology Dialysis Transplantation, 2003
- Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapyAmerican Journal of Kidney Diseases, 2003
- Antibodies against rHuEPO: native and recombinant.Nephrology Dialysis Transplantation, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Antibodies against Recombinant Human Erythropoietin in a Patient with Erythropoietin-Resistant AnemiaNew England Journal of Medicine, 1996
- Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell AplasiaNew England Journal of Medicine, 1996